The business has successfully expanded its share in a highly fragmented market from 4% in 2007 to 11% in 2024 in the US through a combination of its “cluster” strategy and bolt-on acquisitions.
Apollo for Biologics: Provides a centralized platform to submit sample submission forms, track samples, and exchange documents all in one place, ensuring accuracy and saving time.